Nitric Oxide in Sepsis: Of Mice and Men

Sepsis

Volumn 1, Issue 2, 1998, Pages 93-100

  Vallance, Patrick ^a   Charles, Ian ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002261782     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009772307518     Document Type: Article

References (60)

1. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995;9: 1319-1330.
2. Vallance P, Moncada S. Role of endogenous nitric oxide in septic shock. New Horiz 1993;1:77-87.
3. Rees DD, Cellek S, Palmer RMJ, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 1990;173:541-47.
4. Gray GA, Schott C, Julou-Schaeffer G, Felming I, Parratt JR, Stoclet J-C. The effects of inhibitors, of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 1991;103:1218-24.
5. Zembowicz A, Vane J. Induction of nitric oxide synthase activity by toxic shock syndrome toxin I in a macrophage-monocyte cell line. Proc Natl Acad Sci USA 1992;89: 2051-55.
6. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule, Biochem Biophys Res Common 1988;167:87-94.
7. Palmer RMJ, Bridge L, Foxwell NA. Moncada S. The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 1993;105:11-12.
8. Stadler J, Billiar TR, Curran RD, et al. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 1991;250:C910-C916.
9. Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V & Moncada S. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 1996; 314:877-880.
10. Nguyen T, Nrunson D, Crespi Cl, et al. DNA damage and mutation in human cells exposed to nitric oxide. Proc Natl Acad Sci USA 1992;89:3030-34.
11. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-24.
12. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990;172:1132-38.
13. Thiemermann C, Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysacchardies in the rate in vivo. Eur J Pharmacol 1990;182: 591-95.
14. Hutcheson IR, Whittle BJR, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rate. Br J Pharmacol 1990;101:815-20.
15. Boughton-Smith NK, Evans SM, Laszlo F, Whittle BJR, Moncada S. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 1993;110:1189-95.
16. Moncada S, Higgs EA. The L-arginine:nitric oxide pathway. N Engl J Med 1994;2002-2005.
17. Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide in septic shock: how much is beneficial? Lancet 1991;338: 1555-57.
18. G-methyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leuk Biol 1990;48:565-69.
19. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992;26:48-57.
20. Radomski MW, Vallance P, Whitley G, Foxwell N, Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine-induced nitric oxide. Cardiovasc Res 1993;27:1380-92.
21. Kubes P, Suzuki M, Granger D. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-55.
22. De Belder AJ, Radomski MW, Why HJF, et al. Nitric oxide synthase activity in human myocardium. Lancet 1993;341: 84-85.
23. Wei X-Q, Charles IG, Smith A, et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995;375:408-411.
24. MacMicking JD, Nathan C, Hom G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995;81:641-650.
25. Ochoa JB, Udekwu AO, Billiar Tr, et al. Nitrogen oxide levels in patients following trauma and during sepsis. Ann Surg 1991;214:621-16.
26. Hibbs JB Jr, Westenfelder C, Taintor R, et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992;89:867-77.
27. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991;338:1557-58.
28. Lorente JA, Landin L, de Pable R, et al. L-arginine pathway in the sepsis syndrome. Crit Care Med 1993;21:1287-95.
29. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effect of a nitric oxide synthase inhibitor in patients with septic shock: a randomised study. Cardiovasc Res 1994;28:34-39.
30. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 1993; 11:1375-1380.
31. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994;89: 2035-2040.
32. Calver A, Collier J, Vallance P. Nitric oxide and cardiovascular control. Exp Physiol 1993;78:303-326.
33. Bhagat K, Vallance P. Induction of nitric oxide synthase in healthy volunteers. American Heart Association. 69th Congress. Circulation 1996;94:856P(Suppl.).
34. Grover R, Jaccardelli D, Colice G, Guntupalli K, Watson D, Vincent J-L. The cardiovascular effects of 546C88 in human septic shock. Int Care Med 1995;21:S21.
35. Grover R, Bakker J, McKuckie A, Andersson J, LeGall J-R. The nitric oxide synthase inhibitor 546C88 promotes the resolution of shock in patients with severe sepsis. Crit Care in press (abstract).
36. Kilbourn RG, Cromeens DM, Chelly FD, Griffith OW. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. Crit Care Med 1994;22:1835-40.
37. Gray DW, Marshall I. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol 1992;107: 684-90.
38. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994;120:771083.
39. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 1994;129:142-7.
40. Geller DA, Nussler AK, Di Silvio M, et al. Cytokines, endotoxin and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993;90:522-26.
41. Geller DA, Nussler AK, Di-Silvio M, et al. Cytokines, endotoxin and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993;90:522-6.
42. Gross SS, Levi RL. Tetrahydrobiopterin synthesis: an absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle cells. J Biol Chem 1993; 26:25722-20.
43. Bogle RG, Whitley GS, Soo SC, Johnstone AP, Vallance P. Effect of anti-fungal imidazoles on mRNA levels and enzyme activity of inducible nitric oxide synthase. Br J Pharmacol 1994;111:1257-61.
44. Mihae YU, Tomasa G. A double-blind, prospective, randomized trial of ketaconazole, a thromboxane synthetase inhibitor; in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993;21:1635-44.
45. Bogle RJ, Vallance P. Functional effects of anti-fungal imidazoles in inducible nitric oxide synthase: making the enzyme calmodulin dependent. Br J Pharmacol 1996;117:1053-1058.
46. Szabo C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994;91:12472-12476.
47. Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR. Aminoguanidine attenuates the delayed circulatory failure and improves survival in reodent models of endotoxic shock. Br J Pharmacol 1995;114:1666-1172.
48. Billar T. Personal communication.
49. Nava E, Wiklund NP, Salazar FJ. Changes in nitric oxide release in vivo in response to vasoactive substances. Br J Pharmacol 1996;119:1211-1216.
50. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arterial tone in man. Lancet 1989;ii:997-1000.
51. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 1994;93:2236-2243.
52. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342: 1510-1513.
53. Sakurai H, Kohsaka H, Liu MF, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995;96:2357-2363.
54. De Vera ME, Shapiro RA, Nussler AK, et al. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 1996;93:1054-1059.
55. Liu ZZ, Cui S, Billiar TR, et al. Effects of hepatocellular mitogens on cytokine-induced nitric oxide synthesis in human hepatocytes. J Leukoc Biol 1996;60:382-388.
56. Palmer RM, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993;193:398-405.
57. Charles IG, Palmer RMJ, Hickery MS, et al. Cloning, characterization and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 1993;90:11419-11423.
58. Mock BA, Krall MM, Byrd LG, et al. The inducible form of nitric oxide synthase (NOS2) isolated from murine macrophages maps near the nude mutation of mouse chromosome II. Eur J Immunogenetics 1994;21:231-238.
59. Xu W, Charles IG, Moncada S, et al. Mapping of the genes encoding human inducible and endothelial nitric oxide synthase (NOS2 and NOS3) to the pericentric region of chromosome 17 and to chromosome 7, respectively. Genomics 1994;21:419-422.
60. Xu W, Charles IG, Liu L, Koni PA, Moncada S, Emson P. Molecular genetic analysis of the duplication of human inducible nitric oxide synthase (NOS2) sequences. Biochem Biophys Res Comms 1995;212:466-472.